Atlantis Highlights in Chemistry and Pharmaceutical Sciences
The online ISSN of Atlantis Highlights in Chemistry and Pharmaceutical Sciences is 2590-3195.
- Editor-in-Chief : Gu He, Sichuan University, Chengdu, China
- Associate Editor : Guiyin Li, Guilin University of Electronic Technology, Guilin, China
- Editor : Zuhua Wang, Guiyang College of Traditional Chinese Medicine, Guiyang, China
All articles published in proceedings in this series are submitted for indexation in CPCI (part of Clarivate's Web of Science), CNKI, Wanfang Data and Google Scholar. Where applicable, they are also submitted to Ei Compendex and Scopus. For any information about the indexation of a particular proceedings in this series, you are requested to contact the conference organizers (see individual proceedings pages for details) as we are not able to respond to messages received directly from participants.
Open Access & Publication Fees
Atlantis Highlights in Chemistry and Pharmaceutical Sciences is an open access proceedings series, meaning that all articles are immediately and permanently free to read, download, copy & distribute under the terms of the applicable end-user license (refer to the Copyright & End-User License section on this page for further details). The online publication of each proceedings is sponsored by the conference organizers and hence no additional publication fees are required.
Copyright & End-User License
The copyright of all articles published in this series remains with the Authors, i.e. Authors retain full ownership of their article. Permitted third-party reuse of the open access articles is defined by the applicable Creative Commons (CC) end-user license which is accepted by the Authors upon submission of their paper. All articles in Atlantis Highlights in Chemistry and Pharmaceutical Sciences are published under the CC BY-NC 4.0 license, meaning that end users can freely share an article (i.e. copy and redistribute the material in any medium or format) and adapt it (i.e. remix, transform and build upon the material) on the condition that proper attribution is given (i.e. appropriate credit, a link to the applicable license and an indication if any changes were made; all in such a way that does not suggest that the licensor endorses the user or the use) and the material is only used for non-commercial purposes. For more information, please refer to the OA licensing and copyright section in the Springer Nature Open Access Policies for books.
All proposals for proceedings to be published in this series are first evaluated by a Series Editor(s) and/or a scientific evaluation committee consisting of senior researchers in the relevant field. If accepted, the peer review process for the individual articles within each proceedings is under the responsibility of the conference organizers and the Guest Editors of each volume, who are committed to conducting the peer review in line with international scientific standards. The Series Editor(s) subsequently also perform(s) a final check of the scientific quality of the accepted papers before the articles are released for publication. For more information, please refer to the individual proceedings page and/or the conference website.
Code of Ethics & Malpractice Statement
Atlantis Press adheres to the ethical frameworks and guidelines of the Committee on Publication Ethics (COPE), including the COPE Core Practices and the Principles of Transparency and Best Practice in Scholarly Publishing. All ethical and misconduct cases for this series are handled according to these guidelines. For proceedings in particular, Atlantis Press also applies the IEEE Conference Standards for conference ethics and quality control. For detailed information on current conference ethics and quality control in proceedings publications, please read the IEEE white paper which has been endorsed by Atlantis Press. Note that the editorial team of Atlantis Highlights in Chemistry and Pharmaceutical Sciences verifies the originality of submitted manuscripts using similarity detection software.
Each article that is published in a proceedings in this series is assigned a Digital Object Identifier (DOI). DOIs are standardized digital identities which can be used to cite and link to electronic content. A DOI is guaranteed to never change, so can be used as a persistent identifier to permanently link to an electronic article no matter where it is stored. More information on how to cite and use DOIs can be found here.
Atlantis Press is committed to the permanent availability and preservation of scholarly research and to ensure accessibility to this research by converting and upgrading digital file formats to comply with new technology standards. Besides maintaining its own digital archive, Atlantis Press therefore collaborates with the National Library of the Netherlands which permanently archives all Atlantis Press content in their “e-Depot”. All volumes of Atlantis Highlights in Chemistry and Pharmaceutical Sciences are uploaded to this e-Depot after publication to guarantee permanent archiving of the articles. Note that the e-Depot is available through on-site access at the National Library of the Netherlands and if Atlantis Press would be unable to provide access to content on its own platform (temporarily, in an emergency or permanently) access to the e-Depot can be provided to the global public on request.
All Atlantis Press proceedings can be ordered in print, either as a bulk order through the conference organizers or individually. If you wish to obtain an individual print copy of any proceedings in this series, you can order this directly through our partner Curran Associates. Please visit their website for more details.